Information contained on this page is provided by an independent third-party content provider. Frankly and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact firstname.lastname@example.org
SOURCE Aesculap, Inc.
Demonstration Course in Operative Microneurosurgery to be held February 18-21, 2018 at Barrow Neurological Institute in Phoenix, Arizona
CENTER VALLEY, Pa., Dec. 19, 2017 /PRNewswire/ -- Aesculap, Inc. is pleased to announce its joint partnership with Barrow Neurological Institute to host a live neurosurgery course. Aesculap Academy, the company's continuing education division, will facilitate this first-ever U.S. course, in conjunction with the expertise of Barrow's neurosurgical team at its state-of-the-art facility.
Mirrored after the Helsinki course, this will showcase approaches and microsurgical techniques in live operations on various lesions (aneurysms, AVMs, cavernous malformation, extrinsic and intrinsic tumors and EC/IC bypass surgery). During the course, there will be four to six surgeries per day. Professors will discuss the cases and present microsurgical videos between and after the operations. The operative schedule runs every day from 8:00 am to approximately 4:00 pm, followed by case discussions and lectures.
The course will be led by Barrow Chairman, Michael T. Lawton, MD, President and CEO, Professor and Chair, Department of Neurological Surgery Chief, Neurovascular Surgery. The following Barrow faculty members will support the four day course offering:
Andrew S. Little, MD - Associate Professor, Department of Neurological Surgery, Surgical Director, Barrow Pituitary Center & Barrow Interdisciplinary Skull Base Program
Peter Nakaji, MD - Professor and Neurosurgery Education Chair, Department of Neurological Surgery, Program Director, Neurosurgery Residency Program, Director, Division of Minimally Invasive Neurosurgery
Randall Porter, MD - Professor, Department of Neurological Surgery, Director, Interdisciplinary Skull Base Program
Nader Sanai, MD - J.N. Harber Professor, Department of Neurological Surgery Director, Barrow Brain Tumor Research Center, Director, Division of Neurosurgical Oncology, Associate Director, Neurosurgery Residency Program
For additional information and to register, visit http://aesculap.cvent.com/BNI.
About Aesculap, Inc.
Aesculap, Inc., a B. Braun company, is part of a 180-year-old global organization focused on meeting the needs of an ever-changing healthcare community. Through close collaboration with its customers, Aesculap provides advanced technologies for general surgery, neurosurgery and closure technologies. Aesculap continues a proud heritage of leadership and responsiveness as we strive to deliver products and services that improve the quality of patients' lives. For more information, call 800-282-9000 or visit aesculapusa.com.
About The Aesculap Academy®
The Aesculap Academy, is a B.Braun company, which has been protecting and improving people's health for more than 175 years. Through courses, hands-on trainings and symposia, the Aesculap Academy honors its parent company's promise of sharing expertise.
About Barrow Neurological Institute
Barrow Neurological Institute at Dignity Health St. Joseph's Hospital and Medical Center in Phoenix is internationally recognized as a leader in neurosurgery, neurology, neurological research and patient care. Consistently voted among the top facilities in the United States for neurological care, Barrow treats patients with a wide range of neurological conditions, including brain and spinal tumors, cerebrovascular conditions, concussions and neuromuscular disorders. Its surgeons perform more neurosurgeries annually than any hospital in the nation. Barrow is proud to be home of the Muhammad Ali Parkinson Center. For more information, please visit thebarrow.org.
View original content with multimedia:http://www.prnewswire.com/news-releases/aesculap-inc-and-barrow-neurological-institute-partner-to-host-live-neurosurgery-course-300573244.html
©2017 PR Newswire. All Rights Reserved.